Sept 12 (Reuters) - Orphazyme A/S ORPHA.CO :
* H1 NET LOSS DKK 12.8 MILLION VERSUS PROFIT DKK 62.5
MILLION YEAR
AGO
* FINANCIAL OUTLOOK FOR YEAR IS UNCHANGED
* IS INVESTIGATING ITS CURRENT CAPITAL STRUCTURE TO
POTENTIALLY
STRENGTHEN EQUITY AND LIQUIDITY OF COMPANY
* STRENGTHENED EQUITY AND LIQUIDITY MAY RESULT IN ENGAGEMENT
IN
ACTIVITIES AND INVESTMENTS RELATED TO BIOPHARMACEUTICAL RESEARCH
* LIQUIDATION OF UNITS IN US, SWITZERLAND EXPECTED TO BE
FINALIZED
IN H1 202
Source text for Eikon: ID:nGNE8prYYR
Further company coverage: ORPHA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))